Can peptide receptor radionuclide therapy be safely applied in florid bone metastases of gastroenteropancreatic neuroendocrine tumours?

被引：0

作者：

Sabet, Amir ^{[1
]}

Yong-Hing, Charlotte ^{[2
]}

Ezziddin, Khaled ^{[1
]}

Ahmadzadehfar, Hojjat ^{[1
]}

Guhlke, Stefan ^{[1
]}

Gruenwald, Frank ^{[3
]}

Biersack, Hans Juergen ^{[1
]}

Ezziddin, Samer ^{[1
]}

机构：

[1] Dept Nucl Med, Bonn, Germany

[2] Univ British Columbia, Vancouver, BC, Canada

[3] Univ Hosp, Frankfurt, Germany

来源：

JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

1183

引用

页数：2

共 50 条

[21] Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours [J].

Elston, Marianne S. ;

Love, Amanda ;

Kevat, Dev ;

Carroll, Richard ;

Siow, Zhen Rong ;

Pattison, Sharon ;

Boyle, Veronica ;

Segelov, Eva ;

Strickland, Andrew H. ;

Wyld, David ;

Gauci, Richard ;

Kennedy, Kim ;

Ransom, David .

CANCER MEDICINE, 2021, 10 (23) :8405-8411

[22] Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours [J].

Samuel Adant ;

Girish M. Shah ;

Jean-Mathieu Beauregard .

European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 :907-921

[23] The role of peptide receptor radionuclide therapy in patients with lung neuroendocrine tumours [J].

Filice, Angelina ;

Fraternali, Alessandro ;

Fioroni, Federica ;

Froio, Armando ;

Di Paolo, Maria Liberata ;

Casali, Massimiliano ;

Roncali, Massimo ;

Grassi, Elisa ;

Asti, Mattia ;

Versari, Annibale .

JOURNAL OF NUCLEAR MEDICINE, 2012, 53

[24] Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized? [J].

Michael S. Hofman ;

Rodney J. Hicks .

European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 :211-213

[25] Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized? [J].

Hofman, Michael S. ;

Hicks, Rodney J. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (02) :211-213

[26] Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours [J].

Adant, Samuel ;

Shah, Girish M. ;

Beauregard, Jean-Mathieu .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (04) :907-921

[27] Peptide receptor radionuclide therapy for advanced gastroenteropancreatic neuroendocrine tumors - from oncology perspective [J].

Kolasinska-Cwikla, Agnieszka ;

Lowczak, Anna ;

Maciejkiewicz, Katarzyna ;

Cwikla, Jaroslaw B. .

NUCLEAR MEDICINE REVIEW, 2018, 21 (02) :115-124

[28] Surgery enhances the effectiveness of peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumors [J].

Tobias, Joseph ;

Abou Azar, Sara ;

Gujarathi, Rushabh ;

Nordgren, Rachel ;

Vaghaiwalla, Tanaz ;

Millis, J. Michael ;

Feinberg, Nicholas ;

Liao, Chih-Yi ;

Keutgen, Xavier M. .

SURGERY, 2025, 177

[29] Quality Of Life in Patients with Neuroendocrine Gastroenteropancreatic Tumors Treated with Peptide Receptor Radionuclide Therapy [J].

Georgakopoulos, A. ;

Liotsou, T. ;

Chatziioannou, S. N. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 :S691-S691

[30] Efficacy of Peptide Receptor Radionuclide Therapy in Patients with Advanced Bronchial Neuroendocrine Tumours [J].

Koffas, A. ;

Popat, R. ;

Mohmaduvesh, M. ;

Quigley, A. M. ;

Navalkissoor, S. ;

Caplin, M. ;

Toumpanakis, C. .

NEUROENDOCRINOLOGY, 2016, 103 :81-81

← 1 2 3 4 5 →